Unveiling the Complex Role of Exosomes in Alzheimer's Disease

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Jun 24

PMID 38911990

Authors

Mingyue Sun

Zhuoyou Chen

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative illness, characterized by memory loss and cognitive decline, accounting for 60-80% of dementia cases. AD is characterized by senile plaques made up of amyloid β (Aβ) protein, intracellular neurofibrillary tangles caused by hyperphosphorylation of tau protein linked with microtubules, and neuronal loss. Currently, therapeutic treatments and nanotechnological developments are effective in treating the symptoms of AD, but a cure for the illness has not yet been found. Recently, the increased study of extracellular vesicles (EVs) has led to a growing awareness of their significant involvement in neurodegenerative disorders, including AD. Exosomes are small extracellular vesicles that transport various components including messenger RNAs, non-coding RNAs, proteins, lipids, DNA, and other bioactive compounds from one cell to another, facilitating information transmission and material movement. There is growing evidence indicating that exosomes have complex functions in AD. Exosomes may have a dual role in Alzheimer's disease by contributing to neuronal death and also helping to alleviate the pathological progression of the disease. Therefore, the primary aim of this review is to outline the updated understandings on exosomes biogenesis and many functions of exosomes in the generation, conveyance, distribution, and elimination of hazardous proteins related to Alzheimer's disease. This review is intended to provide novel insights for understanding the development, specific treatment, and early detection of Alzheimer's disease.

Citing Articles

An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.

Guo H, Yang R, Cheng W, Li Q, Du M Int J Mol Sci. 2025; 26(5).

PMID: 40076682 PMC: 11900270. DOI: 10.3390/ijms26052059.

HIV-1 gp120 Interactions with Nicotine Modulate Mitochondrial Network Properties and Amyloid Release in Microglia.

Graur A, Erickson N, Sinclair P, Nusir A, Kabbani N Neurochem Res. 2025; 50(2):103.

PMID: 39992414 PMC: 11850467. DOI: 10.1007/s11064-025-04357-3.

Effect of acupuncture on the gait disturbance and hemodynamic changes in the prefrontal cortex: a study protocol for a randomized controlled trial.

Hong Z, Zhang S, Zhang S, Zhao Y, Ye X, Shu X Front Neurol. 2025; 15:1444873.

PMID: 39882359 PMC: 11777019. DOI: 10.3389/fneur.2024.1444873.

Non-Drug and Non-Invasive Therapeutic Options in Alzheimer's Disease.

Sovrea A, Bosca A, Dronca E, Constantin A, Crintea A, Sufletel R Biomedicines. 2025; 13(1).

PMID: 39857667 PMC: 11760896. DOI: 10.3390/biomedicines13010084.

Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.

Nakashima M, Suga N, Yoshikawa S, Matsuda S Molecules. 2024; 29(16).

PMID: 39203005 PMC: 11357136. DOI: 10.3390/molecules29163922.

References

Zhang M, Han W, Xu Y, Li D, Xue Q . Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer's Disease. Neuropsychiatr Dis Treat. 2021; 17:269-275. PMC: 7853421. DOI: 10.2147/NDT.S290925. View

Liu C, Wang J, Li L, Wang P . MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Int J Mol Med. 2014; 34(1):160-6. DOI: 10.3892/ijmm.2014.1780. View

Bhat A, Dar K, Anees S, Zargar M, Masood A, Sofi M . Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015; 74:101-10. DOI: 10.1016/j.biopha.2015.07.025. View

Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J . Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019; 15(8):1071-1080. DOI: 10.1016/j.jalz.2019.05.002. View

Siedlecki-Wullich D, Catala-Solsona J, Fabregas C, Hernandez I, Clarimon J, Lleo A . Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease. Alzheimers Res Ther. 2019; 11(1):46. PMC: 6521366. DOI: 10.1186/s13195-019-0501-4. View

Verbeek M, Otte-Holler I, Fransen J, de Waal R . Accumulation of the amyloid-beta precursor protein in multivesicular body-like organelles. J Histochem Cytochem. 2002; 50(5):681-90. DOI: 10.1177/002215540205000509. View

Caruso Bavisotto C, Scalia F, Marino Gammazza A, Carlisi D, Bucchieri F, de Macario E . Extracellular Vesicle-Mediated Cell⁻Cell Communication in the Nervous System: Focus on Neurological Diseases. Int J Mol Sci. 2019; 20(2). PMC: 6359416. DOI: 10.3390/ijms20020434. View

Gupta A, Pulliam L . Exosomes as mediators of neuroinflammation. J Neuroinflammation. 2014; 11:68. PMC: 3994210. DOI: 10.1186/1742-2094-11-68. View

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J . Amyloid-beta: a crucial factor in Alzheimer's disease. Med Princ Pract. 2014; 24(1):1-10. PMC: 5588216. DOI: 10.1159/000369101. View

10.

Hessvik N, Overbye A, Brech A, Torgersen M, Jakobsen I, Sandvig K . PIKfyve inhibition increases exosome release and induces secretory autophagy. Cell Mol Life Sci. 2016; 73(24):4717-4737. PMC: 11108566. DOI: 10.1007/s00018-016-2309-8. View

11.

Winston C, Goetzl E, Schwartz J, Elahi F, Rissman R . Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia. Alzheimers Dement (Amst). 2019; 11:61-66. PMC: 6477776. DOI: 10.1016/j.dadm.2018.11.002. View

12.

Liang T, Zhang Y, Wu S, Chen Q, Wang L . The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets. Front Pharmacol. 2022; 13:845185. PMC: 8889079. DOI: 10.3389/fphar.2022.845185. View

13.

Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A . Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012; 287(25):21384-95. PMC: 3375560. DOI: 10.1074/jbc.M112.340513. View

14.

Bell R, Zlokovic B . Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 2009; 118(1):103-13. PMC: 2853006. DOI: 10.1007/s00401-009-0522-3. View

15.

Benedikter B, Weseler A, Wouters E, Savelkoul P, Rohde G, Stassen F . Redox-dependent thiol modifications: implications for the release of extracellular vesicles. Cell Mol Life Sci. 2018; 75(13):2321-2337. PMC: 5986851. DOI: 10.1007/s00018-018-2806-z. View

16.

Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K . The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif. 2020; 53(3):e12781. PMC: 7106951. DOI: 10.1111/cpr.12781. View

17.

Kandimalla R, Aqil F, Tyagi N, Gupta R . Milk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer. Am J Reprod Immunol. 2020; 85(2):e13349. DOI: 10.1111/aji.13349. View

18.

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View

19.

Reza-Zaldivar E, Hernandez-Sapiens M, Gutierrez-Mercado Y, Sandoval-Avila S, Gomez-Pinedo U, Marquez-Aguirre A . Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease. Neural Regen Res. 2019; 14(9):1626-1634. PMC: 6557105. DOI: 10.4103/1673-5374.255978. View

20.

Baker S, Polanco J, Gotz J . Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice. J Alzheimers Dis. 2016; 54(3):1207-1217. DOI: 10.3233/JAD-160371. View